IGF1 and atrial fibrillation: It has been shown that BGP-15-treatment reduces the incidence of atrial fibrillation (AF) episodes in a transgenic mouse model of HF, and this effect has been associated with the increased phosphorylation of the cardiac-specific insulin-like growth factor 1 (IGF1) receptor [16].